Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 761–780 of 17,529 recalls

March 7, 2025· ASEGUA THERAPEUTICS LLC

Recalled Item: Sofosbuvir and Velpatasvir

The Issue: Defective Container: blister packs not properly sealed resulting

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2025· Consumer Product Partners, LLC

Recalled Item: [CORRECT FRONT PANEL] Hydrogen Peroxide Topical Solution

The Issue: Labeling; Label Mixup; some bottles have an incorrect

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2025· Exela Pharma Sciences LLC

Recalled Item: 8.4% Sodium Bicarbonate Injection

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2025· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Super-Potent Drug: Out of specification potency results were

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2025· Slate Run Pharmaceuticals

Recalled Item: Cinacalcet Hydrochloride Tablets 60 mg

The Issue: CGMP deviations: The presence of nitrosamine impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2025· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Super-Potent Drug: Out of specification potency results were

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 7, 2025· Slate Run Pharmaceuticals

Recalled Item: Cinacalcet Hydrochloride Tablets 30 mg

The Issue: CGMP deviations: The presence of nitrosamine impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 6, 2025· QuVa Pharma, Inc.

Recalled Item: fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 6, 2025· QuVa Pharma, Inc.

Recalled Item: fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 6, 2025· QuVa Pharma, Inc.

Recalled Item: fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 5, 2025· L'Oreal USA

Recalled Item: La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne...

The Issue: cGMP Deviations: The recall was initiated due to

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 5, 2025· L'Oreal USA

Recalled Item: La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System

The Issue: cGMP Deviations: The recall was initiated due to

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 5, 2025· L'Oreal USA

Recalled Item: La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne...

The Issue: Chemical Contamination: This recall has been initiated due

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 5, 2025· Golden State Medical Supply Inc.

Recalled Item: PRASUGREL TABLETS

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 5, 2025· Strides Pharma, Inc.

Recalled Item: Testosterone Gel 1%

The Issue: Presence of foreign substance: Presence of Benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 5, 2025· Strides Pharma, Inc.

Recalled Item: Testosterone Gel 1%

The Issue: Presence of foreign substance: Presence of Benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 5, 2025· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 4, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Gabapentin Capsules

The Issue: Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
March 4, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Gabapentin Capsules

The Issue: Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
March 4, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Tolterodine Tartrate Extended-Release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund